Hurotics Demonstrates Advanced Gait Rehabilitation Exosuit at MEDICA 2025

Exhibiting in the Medtech & Devices Hall (Hall 15, Stand C57-3), the company seizes a strategic platform to introduce its technology to global medical-device buyers and clinical users.

At MEDICA 2025, Hurotics is demonstrating its flagship product, the H-Medi exosuit. Designed as a Class II medical device for lower limb gait rehabilitation assistance, the H-Medi features a lightweight frame combined with precise auxiliary-force control, enabling tailored support of gait cycles. The system incorporates real-time gait-data feedback to adapt assistance dynamically throughout rehabilitation sessions. By integrating wearable technology with advanced biomechanics, Hurotics presents a clinical solution that supports lower-limb rehabilitation in both acute and long-term recovery settings.

With AI capable of predicting disease prognosis with 92% accuracy, H-Medi enhances treatment by analyzing individual gait patterns, resulting in more than a 10% improvement in walking speed. Its on-device AI delivers customized support within two minutes, using adaptive algorithms to evaluate and assist with 95% accuracy while improving gait efficiency by up to 21%. This comprehensive approach enables precise, personalized rehabilitation and addresses the growing challenge of gait disorders in an aging population, while promoting healthier mobility and independence for elderly patients.

During the exhibition, Hurotics is conducting on-site demonstrations of H-Medi for key buyers, including doctors, hospital administrators, and medical device distributors from around the world, who are actively pursuing new partnerships. A major focus is entry into the European market, leveraging MEDICA’s international audience of more than 5,000 companies and 80,000 visitors from over 70 countries annually.

“Participating in MEDICA 2025 is a crucial opportunity for Hurotics to present our unique wearable robot technology on the global stage and establish a strong bridgehead for entering the European market,” said Giuk Lee, CEO of Hurotics. “We are committed to proving the clinical efficacy and innovation of H-Medi at the world’s largest medical device exhibition and building a foundation for growth as a global company.”

Related Links:
Hurotics